Polypill Strategy for Heart Failure With Reduced Ejection Fraction

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 212 participants.

Also called NCT04633005

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 212 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04633005
Other papers using this trial's data
  • Patient Perspectives on a Polypill Strategy for Heart Failure With Reduced Ejection Fraction: A Convergent-Parallel Mixed Methods Study Embedded in a Randomized Clinical Trial Circulation. Population health and outcomes, 2026-02 DOI, PubMed 41212166, PMC13617990 In the PMC Open Access subset under a licence that is not Creative Commons.
  • Polypill for heart failure with reduced ejection fraction: the POLY-HF randomized trial Nature medicine, 2026-08 DOI, PubMed 42393373, PMC13472951 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04633005. Randomized; no masking; primary purpose treatment. Start 2021-11-15 (actual); primary completion 2025-10-15 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Polypill Strategy for Heart Failure With Reduced Ejection Fraction
Acronym
POLY-HF
Condition
Heart Failure
Intervention (Drug)
Polypill
Intervention (Drug)
Control Rx
Lead sponsor
University of Texas Southwestern Medical Center (class: other)

Record details

Record id
cardio:ct-nct04633005
Content hash
5206537b4bdf28cfa2c60c5ed379fb34124c8edb7efa795488c818cc80ac8643